Tvardi Therapeutics has failed its…
Tvardi Therapeutics has failed its first big test as a [...]
Tvardi Therapeutics has failed its first big test as a [...]
Gilead and Arcus’ anti-TIGIT antibody domvanalimab has been tied to [...]
The president and top health officials acknowledged using the leverage [...]
Novo Nordisk is ending all work in cell therapy, including [...]
Johnson & Johnson may be looking to deepen its relationship [...]
President Donald Trump has been pressuring top drugmakers to get [...]
The 2025 edition of Time’s annual “best inventions” list saw [...]
Auto-injector specialist Ypsomed is hopping on the United States manufacturing [...]
Cabaletta Bio’s CAR-T cell therapy successfully eliminated the overreactive B [...]
In an Oct. 9 discussion about innovation, resilience and the [...]